Ophthalmic solutions
AssigneeBausch + Lomb Ireland Limited
InventorsVicki Barniak, Catherine Scheuer, William T. Reindel, John Michael Duex, Andrea E. Siverling
Life of this patent
Estimating the term…
Abstract
An ophthalmically compatible solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the ophthalmically compatible solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the ophthalmically compatible solution, of erythritol; (c) sodium chloride, potassium chloride or any combination thereof; and (d) one or more buffers.
Claims20
An ophthalmically compatible solution, comprising:
- (a) about 0.005 to about 2 wt. %, based on the total weight of the ophthalmically compatible solution, of hyaluronic acid or a salt thereof;
- (b) about 0.01 to about 1 wt. %, based on the total weight of the ophthalmically compatible solution, of erythritol;
- (c) sodium chloride, potassium chloride or any combination thereof;
- and
- (d) one or more buffers;
- wherein the ophthalmically compatible solution is preservative-free.
A method for reducing, ameliorating, treating, or controlling a condition of dry eye, the method comprising:
- administering to an affected eye of a patient an ophthalmically compatible solution comprising (a) about 0.005 to about 2 wt. %, based on the total weight of the ophthalmically compatible solution, of hyaluronic acid or a salt thereof;
- (b) about 0.01 to about 1 wt. %, based on the total weight of the ophthalmically compatible solution, of erythritol;
- (c) sodium chloride, potassium chloride or any combination thereof;
- and (e) one or more buffers;
- wherein the ophthalmically compatible solution is preservative-free.
An ophthalmically compatible solution, consisting essentially of:
- (a) about 0.005 to about 2 wt. %, based on the total weight of the ophthalmically compatible solution, of hyaluronic acid or a salt thereof;
- (b) about 0.01 to about 1 wt. %, based on the total weight of the ophthalmically compatible solution, of erythritol;
- (c) sodium chloride, potassium chloride or any combination thereof;
- and
- (d) one or more buffers;
- wherein the ophthalmically compatible solution is preservative-free.
Dependencies are inferred from the claim text.